251 related articles for article (PubMed ID: 12895609)
21. [Effectiveness of endovascular prostheses as initial treatment for superior vena cava syndrome of malignant cause].
Talens A; Ferrer S; González-Cruz A; Blanco E; García-Ferrer L; Iranzo V; Camps C
Med Clin (Barc); 2013 Jan; 140(2):59-65. PubMed ID: 22237043
[TBL] [Abstract][Full Text] [Related]
22. Thrombosis, anticoagulation and outcomes in malignant superior vena cava syndrome.
Ratzon R; Tamir S; Friehmann T; Livneh N; Dudnik E; Rozental A; Hamburger-Avnery O; Pereg D; Derazne E; Brenner B; Raanani P; Ten Cate H; Spectre G; Leader A
J Thromb Thrombolysis; 2019 Jan; 47(1):121-128. PubMed ID: 30255420
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous Endovascular Stent Placement for Treatment of Malignant Superior Vena Cava Syndrome: A Retrospective Review.
Wu Y; Li Y; Wang M; Li W; Qiu X
Ann Vasc Surg; 2022 Mar; 80():325-332. PubMed ID: 34780937
[TBL] [Abstract][Full Text] [Related]
24. Malignant superior vena cava syndrome: a comparative cohort study of treatment with covered stents versus uncovered stents.
Gwon DI; Ko GY; Kim JH; Shin JH; Yoon HK; Sung KB
Radiology; 2013 Mar; 266(3):979-87. PubMed ID: 23249571
[TBL] [Abstract][Full Text] [Related]
25. Malignant obstruction of superior vena cava: Endovascular stenting using Y-configuration stent in stent technique.
Noor Khairiah AK; Mohamad Nazrulhisham MN; Hazman MN
Med J Malaysia; 2018 Dec; 73(6):407-409. PubMed ID: 30647215
[TBL] [Abstract][Full Text] [Related]
26. Endovascular treatment of malignant superior vena cava syndrome: is bilateral wallstent placement superior to unilateral placement?
Dinkel HP; Mettke B; Schmid F; Baumgartner I; Triller J; Do DD
J Endovasc Ther; 2003 Aug; 10(4):788-97. PubMed ID: 14533962
[TBL] [Abstract][Full Text] [Related]
27. A retrospective stenting study on superior vena cava syndrome caused by lung cancer.
Wei S; Liu J; Li X; Song Z; Dong M; Zhao H; Zhao Q; Chen G; Chen J
Thorac Cancer; 2020 Jul; 11(7):1835-1839. PubMed ID: 32438532
[TBL] [Abstract][Full Text] [Related]
28. Endovascular Treatment of Malignant Superior Vena Cava Syndrome through Upper-Limb Access: A Comparison between Venous-Dedicated and Conventional Stents.
Matthaiou N; Galanakis N; Kehagias E; Kontopodis N; Charalambous S; Kholcheva N; Tsetis K; Mavroudis D; Tsetis D
J Vasc Interv Radiol; 2020 Dec; 31(12):2066-2072. PubMed ID: 33127247
[TBL] [Abstract][Full Text] [Related]
29. [Observation of endovascular stent insertion for non-small cell lung cancer patients with superior vena cava syndrome].
Li F; Sun X; Liang S; Jiang S; Mao L
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):47-51. PubMed ID: 25877319
[TBL] [Abstract][Full Text] [Related]
30. Treatment of malignant obstruction of the superior vena cava with the self-expanding Wallstent.
Stock KW; Jacob AL; Proske M; Bolliger CT; Rochlitz C; Steinbrich W
Thorax; 1995 Nov; 50(11):1151-6. PubMed ID: 8553270
[TBL] [Abstract][Full Text] [Related]
31. Stent placement for the treatment of malignant superior vena cava syndrome - a single-center series of 56 patients.
Sobrinho G; Aguiar P
Arch Bronconeumol; 2014 Apr; 50(4):135-40. PubMed ID: 24360084
[TBL] [Abstract][Full Text] [Related]
32. Rapid Fire: Superior Vena Cava Syndrome.
Zimmerman S; Davis M
Emerg Med Clin North Am; 2018 Aug; 36(3):577-584. PubMed ID: 30037444
[TBL] [Abstract][Full Text] [Related]
33. Retrospective study in 23 patients of the self-expanding sinus-XL stent for treatment of malignant superior vena cava obstruction caused by non-small cell lung cancer.
Mokry T; Bellemann N; Sommer CM; Heussel CP; Bozorgmehr F; Gnutzmann D; Kortes NA; Kauczor HU; Radeleff B; Stampfl U
J Vasc Interv Radiol; 2015 Mar; 26(3):357-65. PubMed ID: 25638748
[TBL] [Abstract][Full Text] [Related]
34. Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer.
Urruticoechea A; Mesía R; Domínguez J; Falo C; Escalante E; Montes A; Sancho C; Cardenal F; Majem M; Germà JR
Lung Cancer; 2004 Feb; 43(2):209-14. PubMed ID: 14739042
[TBL] [Abstract][Full Text] [Related]
35. Superior vena cava obstruction: is stenting necessary?
Marcy PY; Magné N; Bentolila F; Drouillard J; Bruneton JN; Descamps B
Support Care Cancer; 2001 Mar; 9(2):103-7. PubMed ID: 11305067
[TBL] [Abstract][Full Text] [Related]
36. Stent placement in superior vena cava syndrome.
Courtheoux P; Alkofer B; Al Refaï M; Gervais R; Le Rochais JP; Icard P
Ann Thorac Surg; 2003 Jan; 75(1):158-61. PubMed ID: 12537210
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of superior vena cava syndrome in cancer patients with intravascular stent and local thrombolysis].
Zhang F; Wu P; Huang J
Zhonghua Zhong Liu Za Zhi; 2000 Nov; 22(6):507-9. PubMed ID: 11235576
[TBL] [Abstract][Full Text] [Related]
38. A review of endovascular stenting for superior vena cava syndrome in fibrosing mediastinitis.
Deshwal H; Ghosh S; Magruder K; Bartholomew JR; Montgomery J; Mehta AC
Vasc Med; 2020 Apr; 25(2):174-183. PubMed ID: 31804157
[TBL] [Abstract][Full Text] [Related]
39. Long-term results of endovascular stent placement in the superior caval venous system.
Smayra T; Otal P; Chabbert V; Chemla P; Romero M; Joffre F; Rousseau H
Cardiovasc Intervent Radiol; 2001; 24(6):388-94. PubMed ID: 11907745
[TBL] [Abstract][Full Text] [Related]
40. Stenting through a portacath for totally occluded superior vena cava in a case of non-Hodgkin s lymphoma.
Patel TM; Shah SC; Ranjan A; Malhotra H; Patel R; Gupta AK
J Invasive Cardiol; 2003 Feb; 15(2):86-8. PubMed ID: 12556622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]